Tumour travel tours – Why circulating cancer cells value company
Welcome to the New Year and a new issue of the Biomedical Journal, where we learn that travelling with company boosts the metastatic potential of circulating tumour cells, as well as that a worm could be an excellent model to study antidiabetic drugs. In addition, we discover another pair of molecul...
Main Author: | Sophia Julia Häfner |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-02-01
|
Series: | Biomedical Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S231941702030007X |
Similar Items
-
DEVELOPING TOUR PACKAGE PRICE SYSTEM IN TRAVEL BUREAU COMPANIES
by: Jeni Susanti, et al.
Published: (2019-06-01) -
PERANCANGAN SISTEM INFORMASI RUMAH TRAVEL TOUR BAGI PERUSAHAN TOUR DAN TRAVEL
by: Desy Iba Ricoida
Published: (2017-06-01) -
Circulating tumour cells and biomarkers in neuroendocrine tumours
by: Khan, M. S.
Published: (2013) -
Circulating Cell-Free Tumour DNA in the Management of Cancer
by: Glenn Francis, et al.
Published: (2015-06-01) -
Circulating tumour cells at baseline and late phase of treatment provide prognostic value in breast cancer
by: Shuyun Pang, et al.
Published: (2021-06-01)